1. Home
  2. NBY vs SNEX Comparison

NBY vs SNEX Comparison

Compare NBY & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$17.08

Market Cap

398.2M

Sector

N/A

ML Signal

HOLD

Logo StoneX Group Inc.

SNEX

StoneX Group Inc.

HOLD

Current Price

$103.93

Market Cap

4.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBY
SNEX
Founded
2000
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
398.2M
4.9B
IPO Year
2007
1994

Fundamental Metrics

Financial Performance
Metric
NBY
SNEX
Price
$17.08
$103.93
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
2.6M
314.7K
Earning Date
11-07-2025
02-04-2026
Dividend Yield
8.46%
N/A
EPS Growth
N/A
10.92
EPS
0.47
5.89
Revenue
$10,302,000.00
$130,897,700,000.00
Revenue This Year
$23.91
N/A
Revenue Next Year
$32.05
$5.74
P/E Ratio
$367.58
$17.52
Revenue Growth
390.34
32.62
52 Week Low
$0.46
$64.42
52 Week High
$11.49
$106.98

Technical Indicators

Market Signals
Indicator
NBY
SNEX
Relative Strength Index (RSI) 87.39 65.40
Support Level $4.31 $94.70
Resistance Level $6.50 $104.22
Average True Range (ATR) 2.10 2.92
MACD 0.95 0.49
Stochastic Oscillator 95.61 95.31

Price Performance

Historical Comparison
NBY
SNEX

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About SNEX StoneX Group Inc.

StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.

Share on Social Networks: